Market revenue in 2023 | USD 1,432.7 million |
Market revenue in 2030 | USD 2,373.5 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.34% in 2023. Horizon Databook has segmented the North America clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounts for the highest number of clinical trials conducted among all regions, which is a major driver for growth of clinical trial supply and logistics market. Significant increase in investments in clinical trials and rise in the number of players in clinical trial supply and logistics market are expected to contribute to growth.
Majority of the clinical trials are conducted in the U.S. and Canada. As the most preferred language in this region is English, it reduces the language barrier, making it suitable for conducting trials. Hence, this region is expected to witness considerable growth in clinical trial supply and logistics market over the forecast period.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America clinical trial supply & logistics market , including forecasts for subscribers. This continent databook contains high-level insights into North America clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account